ABSTRACT
We report the sudden onset of dyspnea and loss of consciousness and fetal bradycardia in a middle‐aged obese nulliparous woman at 39 weeks of gestation during first stage of labor leading to the decision for emergency cesarean section. Still during surgery, the mother underwent cardiac arrest. Transesophageal echocardiography during resuscitation showed right ventricular failure leading to the diagnosis of pulmonary embolism. Return of spontaneous circulation was achieved after emergency administration of thrombolysis with alteplase and cardiopulmonary resuscitation after 40 min. Severe bleeding, coagulopathy and persistent right ventricular failure resulted in persistent hemodynamic instability leading to supracervical hysterectomy and veno‐arterial extracorporal life support. Both mother and baby survived without hypoxic brain injury.
Keywords: amniotic fluid embolism, cardiac arrest, emergency thrombolysis, pregnancy, pulmonary embolism, veno‐arterial

Summary.
Sudden cardiac arrest related to pregnancy is a rare event with difficult differentiation of the cause.
Interdisciplinary decision‐making during emergency situations in pregnant women is of crucial importance.
1. Introduction
The risk of venous thromboembolism and pulmonary embolism (PE) significantly increases during pregnancy with the highest risk directly after delivery [1]. Especially in high‐income countries, acute PE is a leading cause of direct maternal mortality with 1 death per 100,000 maternities [2]. Severe pregnancy‐related PE is a rare but potentially life‐threatening event for both mother and fetus [3]. Evidence on differential diagnosis and management of massive PE compared with amniotic fluid embolism (AFE) is scarce due to the nature of emergency and point‐of‐care setting. We describe the case of a PE during first stage of labor with cardiac arrest after delivery in a patient with 39 weeks of gestation presumably due to fulminant PE. Second, we reviewed standards of interdisciplinary emergency management.
2. Case History
A 41‐year‐old obese (body mass index 36 kg/m2) nulliparous at 39 weeks of gestation was admitted to our hospital (university hospital with high level perinatal care) for planned pharmacological induction of labor with misoprostol. Indication for induction of labor was based on the high‐risk constellation of high maternal age, polyhydramnios and obesity. Fetal sonography throughout the pregnancy suggested a fetus with appropriate growth for gestational age. To our knowledge she had no prior thromboembolic events or coagulation disorders. The patient received 50 μg misoprostol orally three to four times per day with regular cardiotocography and vaginal examinations over 3 days according to local guidelines [4]. After rupture of the membranes and during first stage of labor, she developed a sudden onset of dyspnea with imminent loss of consciousness in the in‐patient setting.
3. Treatment
Immediately, routine emergency protocols were initiated. Peripheral oxygenation was not measurable in initial assessment with only a feeble carotid pulse tangible. Parallelly performed sonographic check for fetal heart action was negative (Figure 1), which led to the interdisciplinary decision (anesthetist and obstetrician) for emergency cesarean section. Seven minutes later, a male neonate was born weighing 3380 g with APGAR scores 1/6/8 after 1, 5, and 10 min respectively. The neonate suffered from severe acidosis (arterial umbilical pH = 6.68, base excess −21.4). Immediate resuscitation measures and consecutive asphyxia treatment were administered on our neonatal intensive care unit. The newborn was discharged after 4 days of asphyxia treatment without any signs of hypoxic brain damage in cranial MRI scan.
FIGURE 1.

(a) Normal cardiotocography (CTG) 2 h before the event; (b) CTG at the time of loss of consciousness with no detectable fetal heart beat. Parallel sonographic check for fetal heart action was negative, too (not shown).
Meanwhile maternal blood gas analysis revealed a severe acidosis (Table 1). Shortly after delivery, still during surgery, the mother went under cardiac arrest for approximately 40 min with initial pulseless cardiac activity and later ventricular fibrillation. Transesophageal echocardiography (TEE) showed severe right ventricular overload with a D‐shaped left ventricle (D sign) and thrombotic material in the central pulmonary artery strongly suggesting fulminant PE. We decided on emergency thrombolysis therapy during surgery. After systemic application of 50 mg alteplase return of spontaneous circulation (ROSC) was accomplished. Parallelly, uterine atonic hemorrhage persisted under oxytocin and relevant blood loss under these measures obliged us to perform supracervical hysterectomy. Due to persistent hemodynamic instability non‐respondent to high dose catecholamines, our heart team simultaneously inserted catheters for veno‐arterial extracorporal membrane oxygenation (ECMO) via the right femoral vessels including an antegrade limb perfusion cannula. Due to continuous intraoperative bleeding massive transfusion protocol was set in place, consisting of 23 red blood cell concentrates, 24 fresh frozen plasma, 4 platelet concentrates, 10 g fibrinogen, 8000 units prothrombin complex concentrates, 1 factor eight concentrate, and 3 mg recombinant activated coagulation factor VIIa. Laboratory measurements suggested disseminated intravascular coagulation (DIC) (Table 1). After 8 h surgery time including extensive intraabdominal packing, the patient was transferred to the surgical intensive care unit. Postoperative computed tomography (CT) scan did not show any residues of PE, but pulmonary edema and acute respiratory distress syndrome. No hypoxic brain damage was detected. Because of pulmonary deterioration, ECMO therapy had to be extended requiring a veno‐arterial venous system. The timeline of our emergency management is depicted in Figure 2. As a direct consequence of hemorrhagic shock and reperfusion syndrome with DIC, the patient had to undergo three re‐laparotomies with packing attempts and ligatures of the iliac arteries to gain control of the bleeding during the first 3 days after the initial event. Antibiotics were started with piperacillin and tazobactam.
TABLE 1.
Intraoperative blood gas analysis and coagulation parameters after emergency cesarean delivery showing acidosis and DIC.
| Parameter | 11:30 | 12:20 | 12:46 | 13:13 | 15:34 |
|---|---|---|---|---|---|
| pH | 6.68 | 6.79 | 6.95 | 7.16 | |
| pCO2 [mmHg] | 127 | 69.6 | 48.2 | 31.4 | |
| pO2 [mmHg] | 57 | 150 | 162 | ||
| Base excess [mmoL/L] | −23.9 | −20.7 | −16.5 | ||
| Sodium [mmoL/L | 134 | 141 | 142 | 141 | |
| Potassium [mmoL/L] | 6.80 | 5.47 | 4.24 | 4.27 | |
| Lactate [mg/dL] | 134 | 140.7 | 143 | 126.5 | |
| Bicarbonate [mmol/L] | 10.3 | 10.5 | 10.9 | ||
| Quick [%] | 11.2% | ||||
| INR | 4.83 | ||||
| aPTT [s] | > 120 | ||||
| AT3 [%] | 29.6 | ||||
| Fibrinogen [g/L] | 0.64 |
FIGURE 2.

Timeline of the case report. ECLS, extracorporal life support; ICU, intensive care unit; ROSC, return of spontaneous circulation.
4. Outcome and Follow‐Up
In the following days, the patient developed acute compartment syndrome in the right lower limb, where ECLS was performed, finally leading to its amputation and emergency cannulation of the opposite limb. Additionally, hypoxic damage led to renal and liver failure indicating dialysis and plasmapheresis, as well as it led to myocardial infarction type II and new onset atrial fibrillation (Table 2). Decannulation of tracheostoma was successfully performed 42 days after delivery. After 6 months on intensive and intermediate care units with treatment of multiple wound healing complications, she was transferred to a general ward within the same hospital and is to be released to postoperative rehabilitation clinic around 80 weeks post cardiac arrest. Maintenance anticoagulation was continued with low‐molecular‐weight‐heparin.
TABLE 2.
Laboratory parameters during the first postpartum days with diagnoses of myocardial infarction type II, acute kidney failure, fulminant liver failure, hyperbilirubinemia, acute pancreatitis.
| Day of cardiac arrest 8 h postpartum | First postoperative day | Second postoperative day | Third postoperative day | |
|---|---|---|---|---|
| Creatinine mg/dL | 1.16 | 2.26 | 2.09 | 3.54 |
| Lactate dehydrogenase U/L | 950 | 6228 | 7855 | 3869 |
| Glutamic oxaloacetic transaminase U/L | 497 | 7538 | 3824 | 5664 |
| Bilirubin mg/dL | 0.8 | 3.5 | 5.5 | 8.1 |
| Creatine kinase U/L | 6633 | 59,843 | ||
| High sensitivity cardiac troponin T pg/mL | 2903 | |||
| Lipase U/L | 2412 | |||
| Leukocytes nL−1 | 8.98 | 10.32 | 12.69 | 15.68 |
| Hemboglobin g/dL | 11.1 | 15.5 | 13.4 | 10.8 |
| Thrombocytes nL−1 | 48 | 43 | 106 | 82 |
5. Discussion
Our case report describes an acute and fulminant PE with cardiac arrest and successful resuscitation by combination of pharmacological thrombolysis and ECLS. It includes all hallmarks of AFE and shows how appropriate emergency management can save two lives.
5.1. Causes of Cardiac Arrest
Sudden onset of dyspnea, hypotension and cardiac arrest can have several causes like myocardial infarction, aortic dissection or pericardial tamponade and PE. As current guidelines recommend, AFE should always be considered as a relevant differential diagnosis in pregnant women with cardiac arrest. However diagnosis of AFE remains a diagnosis of exclusion due to the lack of specific diagnostic measures [5, 6]. Both AFE and PE involve consecutive pulmonary hypertension with right heart failure, which should best be confirmed by TEE [7, 8]. Although postoperative CT scan did not reveal any signs of PE in our case, intraoperative TEE was highly suspicious of thrombotic occlusion and hemodynamics slightly improved after systemic administration of thrombolysis suggesting a successful fragmentation of the thrombus. Still, thoracic CT scans showed pulmonary edema and signs of acute respiratory distress syndrome suggesting AFE. Additionally, our patient suffered from DIC: a hallmark of AFE. On the other hand, cardio‐pulmonary arrest due to PE or lysis therapy can also trigger DIC [9, 10]. A large population‐based cohort revealed a total rate of AFE of 2.5 per 100,000 deliveries and found increased risks among women of 35 years or older, cesarean or instrumental vaginal delivery, polyhydramnios, uterine rupture, placenta previa, eclampsia, and induction of labor [11, 12], of which our patient fulfilled multiple risk factors. Although induction of labor seems to nearly double the risk of AFE, the absolute excess risk remains extremely low and must be weighed against the benefits of induction of labor in certain high‐risk situations. Thromboembolic risk factors like obesity, last stage of pregnancy and age should not be ignored and distinguishing in hindsight between AFE or PE as definitive cause of the event is not possible and highlight the dilemma diagnosis between AFE and PE [13, 14].
5.2. Resuscitation Management
Resuscitative measures are rarely needed on the labor ward, but are critical in the event of cardiac arrest. Considerations of both the mother's and her infant's potential outcome are extremely challenging for the responding team.
Therapeutic management guidelines for resuscitation of a pregnant woman are scarce. Literature agrees that fast and multidisciplinary decision‐making and immediate life support improve survival. Immediate cesarean delivery has shown to not only improve fetal but also maternal outcome as a direct consequence of improved thoracic compliance and the relief of the inferior vena cava [15, 16]. In our case cardiac arrest appeared after emergency cesarean section, which can be explained by the increased preload due to the relief of inferior vena cava. Transporting the patient from the labor room to the operation theater is generally not advised due to the loss of time. In our case nevertheless it had the clear advantage of a better equipped setting for the difficult intubation and the complicated management of hemorrhage later on [16]. Typical therapeutic options for PE include thrombolysis, interventional and surgical thrombectomy with or without ECLS. A recent systematic review analyzed cases of severe PE of which 23% of the women suffered from cardiac arrest: Thrombolysis and surgical thrombectomy were associated with 94% and 86% survival rates respectively; although thrombolysis was successfully applied in most cases, hemodynamic instability persisted with additional need of ECLS in 11% [17]. Thrombolysis during pregnancy and after delivery bears major risk to hemorrhagic shock. Therefore, thrombolysis should be reserved to life‐threatening situations [5] but is not contraindicated in maternal resuscitation under an ongoing surgical procedure [18, 19]. In the presented case our multidisciplinary team of obstetricians, anesthesiologists and heart surgeons primarily decided against surgical thrombectomy due to higher maternal mortality rates and favored thrombolysis knowing the risk of maternal hemorrhage with massive perioperative blood loss. Interventional reperfusion treatment seemed not reasonable due to the loss of time. Therefore, in a life‐threatening situation, thrombolytic treatment should not be withheld because of an ongoing surgical procedure as in our case or as described by Fasullo et al. during pregnancy itself [20].
Many authors described cesarean hysterectomy as part of the management of PE because of the high risk of severe bleeding due to the associated coagulopathy [21, 22]. Initial conservation of the uterus carries a high risk of secondary emergency laparotomy for hysterectomy as reported by Karakosta et al. [21]. In contrary, waiving initial hysterectomy was successfully performed by Vuong et al. with a shorter total surgery time [14]. Atonic uterine bleeding made it impossible in our case to preserve the uterus may necessitate emergency hysterectomy due to a potential high blood loss over a short time. We suggest that even without uterine atony the multiple re‐laparotomies would not have been avoided by uterine conservation.
5.3. Prevention
Prediction of cases like ours can save lives, but is difficult, because commonly used tools like the Wells score or Geneva score are not validated in pregnancy. Cohen et al. compared seven international societal guidelines for diagnosing pregnant women with PE [23]. They emphasized the need for defining a clear risk stratification tool for pregnant patients as thresholds of for example D‐Dimers concentration in blood differs significantly between pregnant and non‐pregnant patients. Van Der Pol et al. suggested in a prospective trial of 510 women a pregnancy‐adapted YEARS algorithm using clinical criteria in relation to D‐Dimer levels to screen for PE [24]. This algorithm could safely rule out PE avoiding up to 65% of CT pulmonary angiographies, hence minimizing radiation exposure of the mother and fetus. As there was no prior thromboembolic event nor coagulation disorder nor prior symptoms of deep vein thrombosis, prediction in our case was not possible. There is a big knowledge gap on how to predict PE and AFE in pregnant women or have a better risk stratification to avoid future emergencies.
Being in the fortunate situation of having relatively low maternal mortality rates due to a well‐equipped health system leaves cases like ours to be unique and tragic for both the family and the involved health care staff. As a consequence, interdisciplinary (midwives, obstetricians, surgeons, anesthesiologists, intensivists, and nurses) emergency drills with mock patients were intensified.
6. Conclusion
The differential diagnosis of AFE and PE remains a clinical challenge. Our case showed that time (during standard working hours), place (university hospital), and the immediate interdisciplinary management ameliorated the individual mortality and morbidity. Administration of thrombolysis in life‐threatening situation should not be delayed. However, major bleeding complications must be anticipated.
Author Contributions
Kristina Killinger: conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, visualization, writing – original draft. Fabian Riedel: conceptualization, data curation, validation, writing – review and editing. Mascha O. Fiedler: writing – review and editing. Thomas Müller: writing – review and editing. Markus Wallwiener: writing – review and editing. Stephanie Wallwiener: writing – review and editing. Michael Elsässer: supervision, writing – review and editing. Markus A. Weigand: writing – review and editing. Dittmar Böckler: writing – review and editing. Philipp Erhart: writing – review and editing. Philippe Grieshaber: writing – review and editing. Thilo Hackert: writing – review and editing. Günter Germann: writing – review and editing. Anna Sophie Scholz: conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, visualization, writing – original draft.
Ethics Statement
The authors have nothing to report.
Consent
Written informed consent was obtained from the patient for their anonymized information and material to be published in this article as open access.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
This version of the manuscript has been published on a preprint server: https://colab.ws/articles/10.21203%2Frs.3.rs‐4280771%2Fv1. Open Access funding enabled and organized by Projekt DEAL.
Funding: The authors received no specific funding for this work.
Data Availability Statement
The clinical dataset used and/or analyzed during the current study is available from the corresponding author on reasonable request.
References
- 1. Sultan A. A., West J., Tata L. J., Fleming K. M., Nelson‐Piercy C., and Grainge M. J., “Risk of First Venous Thromboembolism in and Around Pregnancy: A Population‐Based Cohort Study,” British Journal of Haematology 156, no. 3 (2012): 366–373. [DOI] [PubMed] [Google Scholar]
- 2. Knight M., Bunch K., Felker A., et al., Saving Lives, Improving Mothers' Care‐Lessons Learned to Inform Maternity Care From the UK and Ireland Confidential Enquiries Into Maternal Deaths and Morbidity 2017–19 (Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2021). [Google Scholar]
- 3. Knight M., “Antenatal Pulmonary Embolism: Risk Factors, Management and Outcomes,” BJOG 115, no. 4 (2008): 453–461. [DOI] [PubMed] [Google Scholar]
- 4. “Guideline of the German Society of Gyecology and Obstetrics, Induction of Labour.” S2k, AWMF Registry No. 015–088. 2020.
- 5. Konstantinides S. V., Meyer G., Becattini C., et al., “2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration With the European Respiratory Society (ERS),” European Heart Journal 41, no. 4 (2020): 543–603. [DOI] [PubMed] [Google Scholar]
- 6. Shamshirsaz A. A. and Clark S. L., “Amniotic Fluid Embolism,” Obstetrics and Gynecology Clinics of North America 43, no. 4 (2016): 779–790. [DOI] [PubMed] [Google Scholar]
- 7. Simard C., Yang S., Koolian M., Shear R., Rudski L., and Lipes J., “The Role of Echocardiography in Amniotic Fluid Embolism: A Case Series and Review of the Literature,” Canadian Journal of Anaesthesia 68, no. 10 (2021): 1541–1548. [DOI] [PubMed] [Google Scholar]
- 8. Pilecky D., Sollfrank R., Wiesinger T., Balogh E., and Elsner D., “Echocardiographic Diagnosis of Amniotic Fluid Embolism With Paradoxical Embolism,” European Heart Journal‐Cardiovascular Imaging 22, no. 10 (2021): e150. [DOI] [PubMed] [Google Scholar]
- 9. Leitner J. M., Jilma B., Spiel A. O., et al., “Massive Pulmonary Embolism Leading to Cardiac Arrest Is Associated With Consumptive Coagulopathy Presenting as Disseminated Intravascular Coagulation,” Journal of Thrombosis and Haemostasis 8, no. 7 (2010): 1477–1482. [DOI] [PubMed] [Google Scholar]
- 10. Skolnik S., Ioscovich A., Eidelman L. A., et al., “Anesthetic Management of Amniotic Fluid Embolism–A Multi‐Center, Retrospective, Cohort Study,” Journal of Maternal‐Fetal & Neonatal Medicine 32, no. 8 (2019): 1262–1266. [DOI] [PubMed] [Google Scholar]
- 11. Kramer M. S., Rouleau J., Baskett T. F., Joseph K. S., and Maternal Health Study Group of the Canadian Perinatal Surveillance System , “Amniotic‐Fluid Embolism and Medical Induction of Labour: A Retrospective, Population‐Based Cohort Study,” Lancet 368, no. 9545 (2006): 1444–1448. [DOI] [PubMed] [Google Scholar]
- 12. Kramer M. S., Rouleau J., Liu S., Bartholomew S., Joseph K. S., and for the Maternal Health Study Group of the Canadian Perinatal Surveillance System , “Amniotic Fluid Embolism: Incidence, Risk Factors, and Impact on Perinatal Outcome,” BJOG 119, no. 7 (2012): 874–879. [DOI] [PubMed] [Google Scholar]
- 13. Sitaula S., das D., Sitaula S., and Chhetry M., “Amniotic Fluid Embolism: A Rare Cause of Maternal Collapse–A Case Report,” Clinical Case Reports 8, no. 12 (2020): 3359–3361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Vuong A. D. B., Pham T. H., Bui V. H., et al., “Successfully Conservative Management of the Uterus in Acute Pulmonary Embolism During Cesarean Section for Placenta Previa: A Case Report From Tu Du Hospital, Vietnam and Literature Review,” International Journal of Emergency Medicine 17, no. 1 (2024): 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Morris S. and Stacey M., “Resuscitation in Pregnancy,” BMJ 327, no. 7426 (2003): 1277–1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Pacheco L. D., Saade G., Hankins G. D. V., and Clark S. L., “Amniotic Fluid Embolism: Diagnosis and Management,” American Journal of Obstetrics and Gynecology 215, no. 2 (2016): B16–B24. [DOI] [PubMed] [Google Scholar]
- 17. Martillotti G., Boehlen F., Robert‐Ebadi H., Jastrow N., Righini M., and Blondon M., “Treatment Options for Severe Pulmonary Embolism During Pregnancy and the Postpartum Period: A Systematic Review,” Journal of Thrombosis and Haemostasis 15, no. 10 (2017): 1942–1950. [DOI] [PubMed] [Google Scholar]
- 18. Taylor J. E. A., Ngua C. W., and Carwardine M., “Massive Pulmonary Embolism in Pregnancy: Intra‐Arrest Thrombolysis and Resuscitative Hysterotomy,” BML Case Reports 13, no. 4 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Wenk M., PÖPping D. M., Hillyard S., Albers H., and MÖLlmann M., “Intraoperative Thrombolysis in a Patient With Cardiopulmonary Arrest Undergoing Caesarean Delivery,” Anaesthesia and Intensive Care 39, no. 4 (2011): 671–674. [DOI] [PubMed] [Google Scholar]
- 20. Fasullo S., Maringhini G., Terrazzino G., Ganci F., Paterna S., and di Pasquale P., “Thrombolysis for Massive Pulmonary Embolism in Pregnancy: A Case Report,” International Journal of Emergency Medicine 4 (2011): 69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Karakosta A., Evangelou T., Flindris S., et al., “Systemic Thrombolysis for Treatment of Acute Life‐Threatening Pulmonary Embolism During Cesarean Section Followed by Post‐Partum Rescue Hysterectomy: A Case Report and Review of the Literature,” In Vivo 37, no. 1 (2023): 498–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Krawczyk P., Huras H., Jaworowski A., Tyszecki P., and Kołak M., “Cesarean Section Complicated With Presumed Massive Pulmonary Embolism and Cardiac Arrest Treated With Rescue Thrombolytic Therapy‐Two Case Reports,” Annals of Palliative Medicine 12, no. 1 (2023): 219–226. [DOI] [PubMed] [Google Scholar]
- 23. Cohen S. L., Feizullayeva C., McCandlish J. A., et al., “Comparison of International Societal Guidelines for the Diagnosis of Suspected Pulmonary Embolism During Pregnancy,” Lancet Haematol 7, no. 3 (2020): e247–e258. [DOI] [PubMed] [Google Scholar]
- 24. van der Pol L. M., Tromeur C., Bistervels I. M., et al., “Pregnancy‐Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism,” New England Journal of Medicine 380, no. 12 (2019): 1139–1149. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The clinical dataset used and/or analyzed during the current study is available from the corresponding author on reasonable request.
